CN101575587B - Abortus Brucella vaccine recombinant strain and application thereof in preparing vaccine - Google Patents

Abortus Brucella vaccine recombinant strain and application thereof in preparing vaccine Download PDF

Info

Publication number
CN101575587B
CN101575587B CN2009100858596A CN200910085859A CN101575587B CN 101575587 B CN101575587 B CN 101575587B CN 2009100858596 A CN2009100858596 A CN 2009100858596A CN 200910085859 A CN200910085859 A CN 200910085859A CN 101575587 B CN101575587 B CN 101575587B
Authority
CN
China
Prior art keywords
sequence
bacterial strain
strain
leu
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009100858596A
Other languages
Chinese (zh)
Other versions
CN101575587A (en
Inventor
吴清民
王真
牛建蕊
刘文晓
杨羽
张春燕
任婕
刘文娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Agricultural University
Original Assignee
China Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Agricultural University filed Critical China Agricultural University
Priority to CN2009100858596A priority Critical patent/CN101575587B/en
Publication of CN101575587A publication Critical patent/CN101575587A/en
Application granted granted Critical
Publication of CN101575587B publication Critical patent/CN101575587B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention discloses an abortus Brucella vaccine recombinant strain and an application thereof in preparing vaccine. The recombinant strain is a strain obtained by deactivating capsular polysaccharide synthesis protein gene and carboxyl uridine phosphate decarboxylase gene in the abortus Brucella strain S19. The obtained recombinant strain has small virulence and can be used as vaccines to immunize animals without needs of deactivation. The inoculated animal generates no lipopolysaccharide antibody and the virulent virus strain-infected animal can be distinguished from novel vaccine strain immunized animal by serological reaction. The recombinant strain is beneficial to improving the Brucella vaccine, researching diagnosis and identification reagents and developing the Brucella vaccine and matched diagnosis and identification reagents, and has extremely important significance in deracinating and purifying the global animal Brucella.

Description

A kind of Brucella abortus recombinant strain and the application in the preparation vaccine thereof
Technical field
The present invention relates to a kind of Brucella abortus recombinant strain and the application in the preparation vaccine thereof.
Background technology
Brucellosis is a kind of transmissible disease of infecting both domestic animals and human, also is to be only second to foot and mouth disease in the large animal transmissible disease, has the disease of important politics, economic impact power, and is very severe in the popular situation of countries in the world.The strategy of global for a long time prevention and control brucellosis mainly is to quarantine-slaughter (developed country) or immunization (developing country), and the former slaughters animals such as ill ox, sheep, pig by quarantine is measure, costly, operational difficulty; The latter is by immunization and assist the measure of slaughtering, though can stop the propagation of disease in fauna, but immune animal and clinical infected animal are difficult to differentiate, make infected animal in the medium-term and long-term existence of natural population, serious threat human and animal group's health hinders the elimination and the purification of animal brucellosis.
Be used for seeing that according to now reaching making of China in the world rough type vaccine strain RB51 and vaccine strain S19 are attenuated live vaccines, but the virulence of S19 is strong, the inoculation dam easily causes miscarriage, utilizes serological method not infect with wild strain and distinguishes; And the virulence of RB51 relatively a little less than, though can carry out serological differential diagnosis, the immune efficacy of RB51 is controversial, does not also use in China.So the safety label vaccine strains is the technical bottlenecks of present countries in the world for the brucellosis prevention and control.
Summary of the invention
Purpose of the present invention provides a kind of Brucella abortus recombinant strain and the application in the preparation vaccine thereof.
Recombinant bacterial strain provided by the invention is the bacterial strain that the capsular polysaccharide synthetic proteins gene among Bacillus abortus (Brucella abortus) the bacterial strain S19 and the deactivation of carboxyuridine phosphate decarboxylase gene is obtained with being.
Described Bacillus abortus bacterial strain S19 is existing Bacillus abortus vaccine strain.
Described capsular polysaccharide synthetic proteins can be any capsular polysaccharide synthetic proteins that derives from Bacillus abortus (Brucella abortus), specifically can be the capsular polysaccharide synthetic proteins shown in the sequence 1 of sequence table.The encoding sequence of described capsular polysaccharide synthetic proteins specifically can be the nucleotide sequence shown in the sequence 2 of sequence table.
Described carboxyuridine phosphate decarboxylase can be any carboxyuridine phosphate decarboxylase that derives from Bacillus abortus (Brucella abortus), specifically can be the carboxyuridine phosphate decarboxylase shown in the sequence 3 of sequence table.The encoding sequence of described carboxyuridine phosphate decarboxylase specifically can be the nucleotide sequence shown in the sequence 4 of sequence table.
Can be by any existing method deactivation described capsular polysaccharide synthetic proteins gene and carboxyuridine phosphate decarboxylase gene, as this sequence deletion, external source or endogenous sequence insertion in the genome, homologous recombination, RNA interference etc.
The homologous recombination of deactivation capsular polysaccharide synthetic proteins gene can realize by dna fragmentation DA15 being imported Bacillus abortus bacterial strain S19; Described dna fragmentation DA15 is followed successively by homology arm DA15-1 and homology arm DA15-2 to the downstream from the upstream; Described homology arm DA15-1 and homology arm DA15-2 can with the upstream and downstream identical sequence generation homologous recombination of capsular polysaccharide synthetic proteins encoding sequence in the described strain gene group, the described capsular polysaccharide synthetic proteins of deactivation gene.
The length of described homology arm DA15-1 and homology arm DA15-2 is 400-600bp.
The genomic dna that described homology arm DA15-1 specifically can be with Bacillus abortus bacterial strain S19 is a template, carries out the dna fragmentation that pcr amplification obtains with following primer:
PWUO397 (upstream primer): 5 '-GGAATTCTCAATGTAACCAACTTCA-3 ' (sequence 5 of sequence table);
PWUO398 (downstream primer): 5 '-AAGCTTAGAGGTCATACCTTCCTG-3 ' (sequence 6 of sequence table).
The genomic dna that described homology arm DA15-2 specifically can be with Bacillus abortus bacterial strain S19 is a template, carries out the dna fragmentation that pcr amplification obtains with following primer:
PWUO399 (upstream primer): 5 '-CCTCTAAGCTTATCTGTTTGCTGATGCG-3 ' (sequence 7 of sequence table);
PWUO400 (downstream primer): 5 '-CGGGATCCGCGTTTCGGATAAGATG-3 ' (sequence 8 of sequence table).
The homologous recombination of deactivation carboxyuridine phosphate decarboxylase gene can realize by dna fragmentation DAT being imported Bacillus abortus bacterial strain S19; Described dna fragmentation DAT is followed successively by homology arm DAT-1 and homology arm DAT-2 to the downstream from the upstream; Described homology arm DAT-1 and homology arm DAT-2 can with the upstream and downstream identical sequence generation homologous recombination of carboxyuridine phosphate decarboxylase encoding sequence in the described strain gene group, the described carboxyuridine phosphate decarboxylase gene of deactivation.
The length of described homology arm DAT-1 and homology arm DAT-2 is 400-600bp.
The genomic dna that described homology arm DAT-1 specifically can be with Bacillus abortus bacterial strain S19 is a template, carries out the dna fragmentation that pcr amplification obtains with following primer:
PWUO659 (upstream primer): 5 '-GGAATTCAAGTCTTCTCACCCACATCC-3 ' (sequence 9 of sequence table);
PWUO660 (downstream primer): 5 '-AAGCTTCGTCATCGTGCAATTCTG-3 ' (sequence 10 of sequence table).
The genomic dna that described homology arm DAT-2 specifically can be with Bacillus abortus bacterial strain S19 is a template, carries out the dna fragmentation that pcr amplification obtains with following primer:
PWUO661 (upstream primer): 5 '-TGACGAAGCTTCGCTCGATTGGAAGAAGT-3 ' (sequence 11 of sequence table);
PWUO662 (downstream primer): 5 '-CGGGATTCCCGTTCGCCTGTAAGGA-3 ' (sequence 12 of sequence table).
The virulence that experiment showed, this reorganization bacterium is lower than the maternal bacterial strain that sets out, and immune protection effectiveness is suitable with existing vaccine strain, and has clinical quarantine, diagnosis with immune labeled.Therefore, this reorganization bacterium can be used for preparing brucella vaccine.
Described recombinant bacterial strain can be applicable to prepare the Bacillus abortus disease vaccine.
The present invention also protects a kind of Bacillus abortus disease vaccine, and its activity becomes described recombinant bacterial strain.
The present invention finds, the rough type Bacillus abortus vaccine of deactivation capsular polysaccharide synthetic proteins gene and carboxyuridine phosphate decarboxylase gene is stablized mutant strain and is compared with original maternal bacterial strain-international standard vaccine strain S19, because of the lipopolysaccharides dyssynthesis, its virulence reduces relatively, but immanoprotection action is similar to original strain; Of paramount importance is that this bacterial strain is a rough type, can distinguish vaccine immunity animal and clinical wild toxic bacterial strain infection animal simply by serological technique in reality quarantine practice.The present invention can be applicable to the transformation of brucella disease vaccine, the development of diagnosis identification reagent, is applied to develop brucella disease vaccine and supporting differential diagnosis reagent, and elimination and the purification that promotes global animal brucellosis had crucial meaning.
Description of drawings
Fig. 1 is the pcr amplification electrophorogram of DA15-1 and DA15-2.
Fig. 2 is the pcr amplification electrophorogram of DA15.
Fig. 3 is that pEX18AP-DA15 transformed into escherichia coli DH5 α is after the evaluation figure of pcr amplification.
Fig. 4 is that BamHI and the EcoRI double digestion of pEX18AP-DA15 identified figure.
Fig. 5 is the structure schema of recombinant vectors pEX18AP-DA15.
Fig. 6 is the pcr amplification electrophorogram of DAT-1 and DAT-2.
Fig. 7 is the pcr amplification electrophorogram of DAT.
Fig. 8 is that pEX18AP-DAT transformed into escherichia coli DH5 α is after the evaluation figure of pcr amplification.
Fig. 9 is that BamHI and the EcoRI double digestion of pEX18AP-DAT identified figure.
Figure 10 is the structure schema of recombinant vectors pEX18AP-DAT.
Figure 11 identifies figure for the PCR of reorganization bacterium RB15.
Figure 12 identifies figure for the PCR of reorganization bacterium RB15T.
Figure 13 measures change curve in time for reorganization bacterium RB15T inoculation back mouse spleen carries bacterium.
Figure 14 is the preliminary immunoprotection test-results of reorganization bacterium RB15T inoculation mouse.
Embodiment
Following embodiment is convenient to understand better the present invention, but does not limit the present invention.Experimental technique among the following embodiment if no special instructions, is ordinary method.Used test materials among the following embodiment if no special instructions, is to buy from routine biochemistry reagent shop and obtains.
Bacterial strain and plasmid used in following examples are as follows:
Bacillus abortus (Brucella abortus) bacterial strain 2308 (reference culture), Bacillus abortus (Brucella abortus) bacterial strain S19 (vaccine strains) are all available from China Veterinary Drugs Supervisory Inst. bacterial classification chamber; Bacillus abortus (Brucella abortus) bacterial strain RB51 (rough type vaccine strains) is from the isolated strains of U.S.'s business men industry Brucella abortus rough type vaccine; (construction process is referring to document: Tung T.Hoang, Gene 1998,212:77-86) for the pEX18AP plasmid.
The structure of embodiment 1, recombinant bacterial strain
Capsular polysaccharide synthetic proteins gene (GenBank AccessionNumber:BAbS19I04980) according in the Bacillus abortus genome designs two pairs of primers, a pair of primer homology arm DA15-1 that is used to increase, and another is used to the DA15-2 that increases to primer.Homology arm DA15-1 is connected the back and forms sequence D A15 with homology arm DA15-2, sequence D A15 is inserted the pEX18AP plasmid, obtains recombinant vectors pEX18AP-DA15.According to two pairs of primers of the carboxyuridine phosphate decarboxylase gene in the Bacillus abortus genome (GenBank Accession Number:BAbS19I19940) design, a pair of primer homology arm DAT-1 that is used to increase, another is used to the DAT-2 that increases to primer.Homology arm DAT-1 is connected the back and forms sequence D AT with homology arm DAT-2, sequence D AT is inserted the pEX18AP plasmid, obtains recombinant vectors pEX18AP-DAT.The recombinant bacterial strain that homologous recombination can obtain deactivation capsular polysaccharide synthetic proteins gene and carboxyuridine phosphate decarboxylase gene takes place in recombinant vectors pEX18AP-DA15 and pEX18AP-DAT and Bacillus abortus bacterial strain S19.
One, the structure of recombinant vectors pEX18AP-DA15
The building process synoptic diagram is seen Fig. 5.
1, the genomic extraction of brucella
Get the Bacillus abortus bacterial strain S19 of 15 μ l deactivations, add 1ml TNE (every liter contains 1.21gTris, 5.84g NaCl, 0.37g EDTA) mixing, 10000r/min is centrifugal, stays precipitation to abandon supernatant.Add the precipitation after the resuspended washing of 135 μ l TNE afterwards.Contain the TNE of 2%Triton X-100, mixing to wherein adding 135 μ l again.Add the freshly prepared N,O-Diacetylmuramidases of 30 μ l (5mg/ml), flick the test tube mixing.30min is hatched in 37 ℃ of water-baths, adds 15 μ l Proteinase Ks (20mg/ml) afterwards, the vortex mixing.2h is hatched in 65 ℃ of water-baths at least.
Add RNAse (making RNAse concentration reach 10 μ g/ml), after agarose gel electrophoresis is identified that the genomic dna that extracts is standby in 4 ℃ of preservations.
2, the upstream fragment DA15-1 (579bp) of pcr amplification capsular polysaccharide synthetic proteins gene and downstream fragment DA15-2 (505bp)
The segmental primer in amplification upstream is as follows:
PWUO397 (upstream primer): 5 '-GGAATTCTCAATGTAACCAACTTCA-3 ';
PWUO398 (downstream primer): 5 '-AAGCTTAGAGGTCATACCTTCCTG-3 '.
Add the EcoRI restriction enzyme site in the upstream primer, add the HindIII restriction enzyme site in the downstream primer.
The segmental primer in amplification downstream is as follows:
PWUO399 (upstream primer): 5 '-CCTCTAAGCTTATCTGTTTGCTGATGCG-3 ';
PWUO400 (downstream primer): 5 '-CGGGATCCGCGTTTCGGATAAGATG-3 '.
Add the HindIII restriction enzyme site in the upstream primer, add the BamHI restriction enzyme site in the downstream primer.
The genomic dna that obtains with step 1 is a template, uses above-mentioned two primers to carrying out touchdown PCR, and parameter is: 94 ℃ of pre-sex change 3min; 94 ℃ of sex change 45s, 2 circulations of 1 ℃ of operation whenever fall in annealing temperature from 65 ℃ to 50 ℃, and each circulation is extended 1min for 72 ℃; Last 72 ℃ are extended 10min eventually.
Amplified production carries out 1% agarose gel electrophoresis to be identified, sees Fig. 1.Among Fig. 1, the pcr amplification product of 1:DA15-1; The pcr amplification product of 2:DA15-2; The 3:DNA molecular weight standard.The result shows, has successfully amplified the purpose fragment.
3, the segmental acquisition of DA15
By pcr amplification upstream fragment DA15-1 is connected with downstream fragment DA15-2, obtains fragment and be the DA15 fragment.The used primer of pcr amplification is as follows:
PWUO397 (upstream primer): 5 '-GGAATTCTCAATGTAACCAACTTCA-3 ';
PWUO400 (downstream primer): 5 '-CGGGATCCGCGTTTCGGATAAGATG-3 '.
The pcr amplification system:
DA15-1 fragment 1ul
DA15-2 fragment 1ul
dNTP(2.5mM) 1ul
Taq enzyme 2ul
10XTaq?buffer 5ul
pWUM397(20pmol/μl) 1ul
pWUM400(20pmol/l) 1ul
Distilled water complements to 50ul 38ul
Amplified production carries out electrophoresis detection, sees Fig. 2.Among Fig. 2, the 1:PCR product; The 2:DNA molecular weight standard.The result shows, has successfully obtained the DAT fragment that DA15-1 is connected with DA15-2.
4, the structure of pEX18AP-DA15 plasmid
The pEX18AP plasmid that extraction contains AMP resistance, SacB gene and lac-Z gene and contains multiple clone site.To be connected with the DA15 fragment of the step 3 of identical double digestion through the pEX18AP plasmid behind BamHI and the EcoRI double digestion.With the recombinant plasmid called after pEX18AP-DA15 that obtains.
Be transformed into bacillus coli DH 5 alpha with pEX18AP-DA15, carry out blue hickie screening then.Single bacterium colony of picking positive strain shakes bacterium and cultivates, and advanced performing PCR identifies that primers designed is as follows:
PWUO397 (upstream primer): 5 '-GGAATTCTCAATGTAACCAACTTCA-3 ';
PWUO400 (downstream primer): 5 '-CGGGATCCGCGTTTCGGATAAGATG-3 '.
The results are shown in Figure 3.Among Fig. 3, the 1:DNA molecular weight standard; 2:pEX18AP-DA15 transforms the PCR product of positive strain.
Extract plasmid then and carry out BamHI and the evaluation of EcoRI double digestion.What enzyme was cut evaluation the results are shown in Figure 4.Among Fig. 4, the 1:DNA molecular weight standard; 2: the double digestion product of recombinant plasmid in the positive strain.
With the bacterial strain propagation that contains recombinant plasmid that obtains, be kept at-80 ℃ standby.
Two, the structure of recombinant vectors pEX18AP-DAT
The building process synoptic diagram is seen Figure 10.
1, the genomic extraction of brucella
Get the Bacillus abortus bacterial strain S19 of 15 μ l deactivations, add 1ml TNE (every liter contains 1.21gTris, 5.84g NaCl, 0.37g EDTA) mixing, 10000r/min is centrifugal, stays precipitation to abandon supernatant.Add the precipitation after the resuspended washing of 135 μ l TNE afterwards.Contain the TNE of 2%Triton X-100, mixing to wherein adding 135 μ l again.Add the freshly prepared N,O-Diacetylmuramidases of 30 μ l (5mg/ml), flick the test tube mixing.30min is hatched in 37 ℃ of water-baths, adds 15 μ l Proteinase Ks (20mg/ml) afterwards, the vortex mixing.2h is hatched in 65 ℃ of water-baths at least.
Add RNAse (making RNAse concentration reach 10 μ g/ml), after agarose gel electrophoresis is identified that the genomic dna that extracts is standby in 4 ℃ of preservations.
2, the upstream fragment DAT-1 (403bp) of pcr amplification carboxyuridine phosphate decarboxylase gene and downstream fragment DAT-2 (408bp)
The segmental primer in amplification upstream is as follows:
PWUO659 (upstream primer): 5 '-GGAATTCAAGTCTTCTCACCCACATCC-3 ';
PWUO660 (downstream primer): 5 '-AAGCTTCGTCATCGTGCAATTCTG-3 '.
Add the EcoRI restriction enzyme site in the upstream primer, add the HindIII restriction enzyme site in the downstream primer.
The segmental primer in amplification downstream is as follows:
PWUO661 (upstream primer): 5 '-TGACGAAGCTTCGCTCGATTGGAAGAAGT-3 ';
PWUO662 (downstream primer): 5 '-CGGGATTCCCGTTCGCCTGTAAGGA-3 '.
Add the HindIII restriction enzyme site in the upstream primer, add the BamHI restriction enzyme site in the downstream primer.
The genomic dna that obtains with step 1 is a template, uses above-mentioned two primers to carrying out touchdown PCR, and parameter is: 94 ℃ of pre-sex change 3min; 94 ℃ of sex change 45s, 2 circulations of 1 ℃ of operation whenever fall in annealing temperature from 65 ℃ to 50 ℃, and each circulation is extended 1min for 72 ℃; Last 72 ℃ are extended 10min eventually.
Amplified production carries out 1% agarose gel electrophoresis to be identified, sees Fig. 6.Among Fig. 1, the 1:DNA molecular weight standard; The pcr amplification product of 2:DAT-1; The pcr amplification product of 3:DAT-2.The result shows, has successfully amplified the purpose fragment.
3, the segmental acquisition of DAT
By pcr amplification upstream fragment DAT-1 is connected with downstream fragment DAT-2, obtains fragment and be the DAT fragment.The used primer of pcr amplification is as follows:
PWUO659 (upstream primer): 5 '-GGAATTCAAGTCTTCTCACCCACATCC-3 ';
PWUO662 (downstream primer): 5 '-CGGGATTCCCGTTCGCCTGTAAGGA-3 '.
The pcr amplification system:
DAT-1 fragment 1ul
DAT-2 fragment 1ul
dNTP(2.5mM) 1ul
Taq enzyme 2ul
10XTaq?buffer 5ul
Pwum659(20pmol/μl) 1ul
pWUM662(20pmol/μl) 1ul
Distilled water complements to 50ul 38ul
Amplified production carries out electrophoresis detection, sees Fig. 7.Among Fig. 7, the 1:PCR product; The 2:DNA molecular weight standard.The result shows, has successfully obtained the DAT fragment that DAT-1 is connected with DAT-2.
4, the structure of pEX18AP-DAT plasmid
The pEX18AP plasmid that extraction contains AMP resistance, SacB gene and lac-Z gene and contains multiple clone site.To be connected with the DAT fragment of the step 3 of identical double digestion through the pEX18AP plasmid behind BamHI and the EcoRI double digestion.With the recombinant plasmid called after pEX18AP-DAT that obtains.
Be transformed into bacillus coli DH 5 alpha with pEX18AP-DAT, carry out blue hickie screening then.Single bacterium colony of picking positive strain shakes bacterium and cultivates, and advanced performing PCR identifies that primers designed is as follows:
PWUO659 (upstream primer): 5 '-GGAATTCAAGTCTTCTCACCCACATCC-3 ';
PWUO662 (downstream primer): 5 '-CGGGATTCCCGTTCGCCTGTAAGGA-3 '.
The results are shown in Figure 8.Among Fig. 8,1:pEX18AP-DAT transforms the PCR product of positive strain; The 2:DNA molecular weight standard.
Extract plasmid then and carry out BamHI and the evaluation of EcoRI double digestion.What enzyme was cut evaluation the results are shown in Figure 9.Among Fig. 9,1: the double digestion product of recombinant plasmid in the positive strain; The 2:DNA molecular weight standard.
With the bacterial strain propagation that contains recombinant plasmid that obtains, be kept at-80 ℃ standby.
Three, the acquisition of the acquisition of recombinant bacterial strain
1, the acquisition of the acquisition RB15 of recombinant bacterial strain
Inoculation 50ul Bacillus abortus bacterial strain S19 cultivates after 24 hours for 37 ℃ in the centrifuge tube that contains the 20mlTSB substratum, and centrifugal thalline also suspends and changes in the 1.5ml centrifuge tube of precooling continuation centrifuge washing 3-4 time over to the tri-distilled water of precooling.Then, add an amount of cold tri-distilled water suspension bacteria liquid, get the pole cup that 87ul bacterium liquid and 3ul recombinant plasmid pEX18AP-DA15 add 1mm, pole cup is put into the BIORAD electroporation apparatus, adjust instrument to the Agr program, shock by electricity by the Pulse button.The inquiry shock parameters is 2.22KV.After the electric shock, in pole cup, add 1ml SOC nutrient solution, change the 1.5ml centrifuge tube over to, leave standstill 10min under the room temperature, place 37 ℃ of shaking table recovery 12-18h.The bacterium liquid that transforms after recovering is coated TSB (penbritin that contains 100ug/ul).Grow single bacterium colony after 5-8 days.Picking list bacterium colony with after 10-100 times of this bacterium liquid dilution, is got 100ul and is coated the TSA plate culture medium that contains 5% sucrose again to 37 ℃ of propagation of TSB liquid nutrient medium (antibiotic-free) 48h.After 3-5 days, grow single bacterium colony, positive bacteria is dropped into performing PCR identify.
The primer that PCR identifies is as follows:
PWUO397 (upstream primer): 5 '-GGAATTCTCAATGTAACCAACTTCA-3 ';
PWUO400 (downstream primer): 5 '-CGGGATCCGCGTTTCGGATAAGATG-3 '.
The PCR qualification result of recombinant bacterial strain RB15 is seen Figure 11.Among Figure 11, the 1:DNA molecular weight standard; 2: recombinant bacterial strain RB15; 3: Bacillus abortus bacterial strain S19.
The result shows, obtained the Bacillus abortus bacterial strain of deactivation capsular polysaccharide synthetic proteins by double exchange, with its called after recombinant bacterial strain RB15.
2, the acquisition of recombinant bacterial strain RB15T
According to the program of step 1, be female parent with the recombinant bacterial strain RB15 that obtains, by electric transformation technology recombinant plasmid pEX18AP-DAT is imported, the screening positive bacteria is dropped into performing PCR and is identified.
The primer that PCR identifies is as follows:
PWUO659 (upstream primer): 5 '-GGAATTCAAGTCTTCTCACCCACATCC-3 ';
PWUO662 (downstream primer): 5 '-CGGGATTCCCGTTCGCCTGTAAGGA-3 '.
The PCR qualification result of recombinant bacterial strain RB15T is seen Figure 12.Among Figure 12, the 1:DNA molecular weight standard; 2: Bacillus abortus bacterial strain S19; 3: recombinant bacterial strain RB15T.
The result shows, has obtained the Bacillus abortus bacterial strain by double exchange deactivation capsular polysaccharide synthetic proteins gene and carboxyuridine phosphate decarboxylase gene, with its called after recombinant bacterial strain RB15T.
The application of embodiment 2, recombinant bacterial strain RB15T
The female mouse of experimental animal: 4-6 week SPF level Balb/C in age, available from Beijing Vital River Experimental Animals Technology Co., Ltd., license licensed licenser licence is numbered SCXK (capital) 2007-0001.
One, virulence is identified
Mouse is divided into four groups at random, 30 every group.Concrete vaccination regimen is as follows:
First group (test group): the recombinant bacterial strain RB15T of inoculation embodiment 1 preparation, every mouse peritoneal dosage of inoculation 0.1ml includes 10 7Bacterium.
Second group (control group 1): inoculation Bacillus abortus bacterial strain 2308, every mouse peritoneal dosage of inoculation 0.1ml includes 10 7Bacterium.
The 3rd group (control group 2): inoculation Bacillus abortus bacterial strain S19, every mouse peritoneal dosage of inoculation 0.1ml includes 10 7Bacterium.
The 4th group (control group 3): inoculation Bacillus abortus rough type vaccine strains RB51, every mouse peritoneal dosage of inoculation 0.1ml includes 10 7Bacterium.
The 1st, 3,4,6 and 10 weeks from every group of mouse, selected 5 respectively at the inoculation back, carry out spleen and carry bacterium amount and serology detection evaluation.
Spleen carries the bacterium amount sees Figure 13 over time.Among Figure 13, WT represents the experimental result of inoculating strain 2308, and S19 represents the experimental result of inoculating strain S19, and RB15T represents to inoculate the experimental result of recombinant bacterial strain RB15T, and RB51 represents the experimental result of inoculating strain RB51.The result shows: after the recombinant bacterial strain RB15T inoculation, the spleen of mouse carries the bacterium amount and prolongs reduction gradually in time, and removing speed in vivo proves that far away faster than S19 and RB51 this bacterial strain may be much shorter than vaccine strains S19 in the intravital time length of mouse.
The serology detected result shows, (China Veterinery Drug Inspection Office makes the mice serum of inoculation Bacillus abortus reference culture and Bacillus abortus vaccine strains S19 by the red plate agglutination test antigen of brucella tiger, when lot number 200801) detecting, all tangible agglutination reaction can appear in 2 minutes, (China Veterinery Drug Inspection Office makes by tube agglutination test antigen, lot number 200603) detected antibody titer reaches more than 1: 100, and the detected result of the mice serum of recombinant bacterial strain RB15T is negative, and the detected result of inoculation recombinant bacterial strain RB6 and RB51 mice serum is negative.
Two, vaccine potency evaluation
Above-mentioned healthy mice is divided into four groups at random, 15 every group.Four groups of mouse are injected recombinant bacterial strain RB15T, Bacillus abortus vaccine strains S19, Bacillus abortus bacterial strain RB51 and PBS respectively, and are specific as follows:
First group (test group): the recombinant bacterial strain RB15T of inoculation embodiment 1 preparation, every mouse peritoneal dosage of inoculation 0.1ml includes 10 7Bacterium.
Second group (vaccine control group): inoculation Bacillus abortus bacterial strain S19, every mouse peritoneal dosage of inoculation 0.1ml includes 10 7Bacterium.
The 3rd group (rough strains of bacteria control group): inoculation Bacillus abortus rough type vaccine strains RB51, every mouse peritoneal dosage of inoculation 0.1ml includes 10 7Bacterium.
The 4th group (blank group): inoculation 0.01M pH7.2 phosphate buffered saline buffer (PBS), every mouse peritoneal dosage of inoculation 0.1ml.
After the above-mentioned bacterial strains inoculation, every group of mouse is divided into three groups (5 of each groups), respectively at inoculation the 12nd week of back, 16 weeks and 20 weeks attacking poison with Bacillus abortus bacterial strain 2308 (Brucella abortus), dosage is 10 6CFU/ml.Take a blood sample after two weeks and cut open extremely and respectively organize mouse, get spleen and weigh and calculate spleen and carry the bacterium quantitative changeization, estimate immune efficacy.Test is provided with three repetitions, results averaged.
The average of spleen carried bacterium quantitative change result as shown in figure 14.Among Figure 14, PBS represents the experimental result of blank group, and S19 represents the experimental result of vaccine control group, and RB15T represents the experimental result of test group, and RB51 represents the experimental result of rough strains of bacteria control group.Mouse body inside fire attack poison is the result show; the immune protection effectiveness of this recombinant bacterial strain RB15T is better than bacterial strain RB51; similar with maternal vaccine strains S19, and this recombinant bacterial strain RB15T has the immunodiagnosis mark, and inoculation animal and clinical infection animal can be differentiated by serological reaction.
Sequence table
<110〉China Agricultural University
<120〉a kind of Brucella abortus recombinant strain and the application in the preparation vaccine thereof
<130>CGGNARY92323
<160>12
<210>1
<211>622
<212>PRT
<213〉Bacillus abortus (Brucella abortus)
<400>1
Met?Ser?Leu?Lys?Tyr?Pro?Trp?Gln?Arg?Leu?Ala?Leu?Leu?Pro?Arg?Ile
1 5 10 15
Ser?Lys?Gln?Ile?Ile?Leu?Val?Leu?Ser?Asp?Cys?Leu?Leu?Leu?Leu?Ala
20 25 30
Ser?Ala?Tyr?Leu?Ala?Phe?Val?Val?Arg?Phe?Gly?Phe?Val?Phe?Val?Pro
35 40 45
Asn?Leu?Ala?Gln?Leu?Phe?Leu?Ile?Leu?Ile?Ala?Pro?Leu?Leu?Ala?Ile
50 55 60
Pro?Val?Phe?Ile?Arg?Phe?Gly?Leu?Tyr?Arg?Ala?Ile?Ile?Arg?Tyr?Leu
65 70 75 80
Ala?Glu?Arg?Ala?Ile?Trp?Ser?Ile?Phe?Gln?Ala?Thr?Ala?Val?Ala?Ala
85 90 95
Leu?Phe?Trp?Val?Ala?Leu?Val?Phe?Leu?Met?Glu?Leu?Tyr?Gly?Ser?Thr
100 105 110
Gly?Leu?Pro?Arg?Ser?Val?Pro?Leu?Leu?Tyr?Trp?Leu?Leu?Ser?Thr?Val
115 120 125
Phe?Ile?Ser?Ala?Ser?Arg?Phe?Gly?Ala?Lys?Trp?Leu?Leu?Arg?Thr?Ala
130 135 140
Glu?His?Asp?Lys?Arg?Tyr?Thr?Ser?Ser?Ala?Leu?Ile?Ile?Gly?Ile?Gly
145 150 155 160
Glu?Pro?Ala?Arg?Gln?Leu?Ala?Thr?Ala?Leu?Arg?Ser?His?Ser?Asp?Thr
165 170 175
Leu?Val?Val?Gly?Phe?Ile?Asp?Pro?Ala?Gly?Gln?Leu?Ala?Gly?Met?Asp
180 185 190
Ile?Ile?Gly?Leu?Arg?Val?Tyr?Arg?Thr?Glu?Glu?Ile?Pro?Ser?Leu?Ile
195 200 205
Glu?Asn?Tyr?Gly?Ile?Lys?Gln?Val?Val?Val?Ser?Glu?Pro?Ala?Leu?Glu
210 215 220
Gln?Lys?Glu?Arg?Gln?Glu?Phe?Ala?Arg?Leu?Leu?Gly?Arg?Leu?Pro?Val
225 230 235 240
Asn?Thr?Arg?Ile?Leu?Pro?Pro?Ile?Ala?Asp?Leu?Thr?Ala?Gly?Lys?Tyr
245 250 255
Leu?Val?Ser?Ala?Leu?Arg?Asn?Val?Glu?Ile?Asp?Asp?Leu?Leu?Gly?Arg
260 265 270
Ser?Pro?Val?Pro?Pro?Asp?Thr?Thr?Leu?Leu?Arg?Glu?Val?Val?Glu?Gly
275 280 285
Arg?Arg?Ile?Met?Ile?Thr?Gly?Ala?Gly?Gly?Ser?Ile?Gly?Ser?Gln?Leu
290 295 300
Cys?Leu?Thr?Ile?Ala?Gln?Trp?Asn?Pro?Ala?Ala?Ile?Val?Leu?Phe?Glu
305 310 315 320
Ser?Ser?Glu?Phe?Ala?Leu?Tyr?Gln?Ile?Asp?Arg?Gln?Leu?Arg?Gln?Phe
325 330 335
Ala?Ser?Cys?Thr?Val?Val?Pro?Val?Leu?Gly?Ser?Val?Arg?Asp?Arg?Ala
340 345 350
Cys?Val?Glu?Lys?Pro?Ile?Arg?Asp?His?Ser?Ile?Asp?Thr?Val?Tyr?His
355 360 365
Cys?Ala?Ala?Tyr?Lys?His?Val?Pro?Leu?Val?Glu?Arg?Asn?Pro?Leu?Val
370 375 380
Gly?Ile?Phe?Asn?Asn?Val?Phe?Gly?Thr?Leu?Glu?Val?Ala?Glu?Ala?Ala
385 390 395 400
Leu?Asn?Thr?Asp?Val?Glu?Arg?Met?Val?Leu?Ile?Ser?Ser?Asp?Lys?Ala
405 410 415
Val?Arg?Pro?Thr?Asn?Val?Met?Gly?Ala?Thr?Lys?Arg?Trp?Ala?Glu?Leu
420 425 430
Val?Ile?Tyr?Tyr?Tyr?Gly?Arg?Leu?Ala?Glu?Gln?Ala?Gly?Lys?Lys?Lys
435 440 445
Ala?Phe?Tyr?Ser?Val?Arg?Phe?Gly?Asn?Val?Leu?Gly?Ser?Asn?Gly?Ser
450 455 460
Val?Val?Pro?Leu?Phe?Arg?Glu?Gln?Ile?Ala?Asn?Gly?Gly?Pro?Val?Thr
465 470 475 480
Leu?Thr?His?Glu?Asp?Met?Thr?Arg?Tyr?Phe?Met?Ser?Ile?Lys?Glu?Ala
485 490 495
Ala?Glu?Leu?Ile?Val?Gln?Ser?Gly?Ala?Ile?Ala?Gln?Ser?Gly?Asp?Thr
500 505 510
Val?Leu?Leu?Glu?Met?Gly?Glu?Pro?Val?Lys?Ile?Arg?Asp?Leu?Ala?Glu
515 520 525
Asn?Met?Ile?Leu?Leu?Ala?Gly?Leu?Thr?Val?Arg?Asn?Glu?Glu?Asn?Pro
530 535 540
Gln?Gly?Asp?Ile?Ala?Ile?Glu?Val?Thr?Gly?Ile?Arg?Glu?Gly?Glu?Lys
545 550 555 560
Met?Tyr?Glu?Glu?Leu?Phe?Tyr?Asp?Pro?Ser?Leu?Ala?Gln?Arg?Thr?Arg
565 570 575
His?Pro?Lys?Ile?Met?Arg?Ala?Pro?Gln?Gly?Ser?Lys?Ala?Val?Val?Asp
580 585 590
Ile?Gln?Glu?Ser?Leu?Ala?Val?Leu?Arg?Thr?Ala?Met?Glu?Lys?Glu?Asp
595 600 605
Ile?Glu?Met?Val?Arg?Lys?Val?Leu?Phe?Glu?Val?Ile?Ala?Ser
610 615 620
<210>2
<211>1869
<212>DNA
<213〉Bacillus abortus (Brucella abortus)
<400>2
atgagtttaa?aatatccttg?gcaaagattg?gcgcttctgc?cgcgcatcag?caaacagatc 60
attctggtgt?tgagcgattg?cctgttgctg?cttgcaagcg?cctatctagc?ttttgtcgtc 120
cgtttcggtt?tcgtcttcgt?acccaatctg?gcgcagcttt?tcctgatcct?gattgcgccg 180
cttctggcca?ttccggtctt?catccgtttt?gggctttacc?gcgccatcat?tcgttatctg 240
gccgagcgcg?ccatctggtc?gatcttccag?gccaccgcag?tcgccgcctt?gttctgggtg 300
gcgctggtgt?tcctgatgga?gctttacggc?agcaccggcc?tgccgcgttc?tgttccgctt 360
ctttattggc?tcctgagtac?ggttttcatt?tccgcaagcc?gcttcggcgc?aaaatggctg 420
ctacgcactg?ccgaacacga?caagcggtat?accagttcag?ccctgataat?cggcattggc 480
gaaccggcgc?gtcagcttgc?gacggccctt?cgcagccata?gcgatacgtt?ggtggtgggt 540
tttatcgatc?ctgccgggca?actggccgga?atggacatta?ttggcctgcg?tgtctatcgc 600
acggaagaaa?ttccaagcct?gatcgaaaat?tacggtatca?agcaggttgt?cgtttcagaa 660
cccgcgctgg?agcagaagga?gcgccaggag?tttgcgcgcc?ttttggggcg?cctgccggtc 720
aatacgcgca?ttcttccgcc?cattgctgat?ctcacggccg?ggaaatatct?cgttagtgcg 780
ctgcgcaatg?tcgagatcga?tgatcttttg?gggcgttcgc?cggttccgcc?tgatacaacg 840
cttctgcgtg?aggtcgtgga?ggggcggcgc?atcatgataa?ccggcgcggg?cggttccatc 900
ggcagccagc?tttgcctcac?gattgcgcaa?tggaacccgg?ctgcgattgt?tctctttgaa 960
tcgagtgagt?ttgcattata?ccagatcgac?aggcagcttc?gccagtttgc?ctcttgcacg 1020
gtggtgccgg?tccttggctc?cgtgcgtgac?cgcgcctgcg?tggaaaaacc?gatccgcgat 1080
cattccatcg?atacggttta?tcactgtgcg?gcttacaagc?atgtgccgct?ggtggagagg 1140
aacccgctgg?tcggcatttt?caacaatgta?ttcggcacgc?tggaggtggc?cgaggcagcg 1200
ttgaacacgg?atgtggaacg?catggtgctg?atctcttccg?acaaggccgt?gcgccccacc 1260
aatgtcatgg?gcgcgaccaa?gcggtgggcg?gaactggtta?tctattatta?cggacggctg 1320
gctgagcagg?ccggcaagaa?aaaagctttc?tattccgtcc?gttttggcaa?tgtgcttggc 1380
tccaacggtt?cggtagtgcc?gcttttccgc?gagcagattg?caaatggcgg?ccccgttacg 1440
ctgacgcatg?aagacatgac?gcgctatttc?atgtccatca?aggaggcggc?ggaactgatc 1500
gtgcagtccg?gcgcgattgc?ccaatccggt?gataccgttc?ttttggaaat?gggtgagccg 1560
gtgaaaatcc?gcgatctggc?cgaaaacatg?atcctgctcg?cgggactcac?cgtgcgcaac 1620
gaggaaaacc?cgcagggcga?tatcgccatt?gaggtgacgg?gtattcgcga?aggcgagaag 1680
atgtatgaag?agcttttcta?cgatccttcg?ctcgcccagc?gcacccgtca?tccgaaaatc 1740
atgcgtgcgc?cccagggcag?caaggccgtg?gtagatattc?aggaaagcct?ggcggtactg 1800
cggaccgcca?tggaaaagga?ggatatcgaa?atggtccgca?aggtgctttt?cgaggtcata 1860
gcttcctga 1869
<210>3
<211>238
<212>PRT
<213〉Bacillus abortus (Brucella abortus)
<400>3
Met?Thr?Thr?Glu?Leu?His?Asp?Asp?Ala?Ser?Gly?Arg?Leu?Ile?Val?Gly
1 5 10 15
Leu?Asp?Val?Pro?Thr?Ile?Ala?Glu?Ala?Glu?Lys?Val?Val?Glu?Glu?Leu
20 25 30
Gly?Asn?Ala?Val?Ser?Phe?Tyr?Lys?Ile?Gly?Tyr?Gln?Leu?Val?Phe?Ala
35 40 45
Gly?Gly?Leu?Asp?Phe?Ala?Lys?Ser?Leu?Val?Ala?Ala?Arg?Lys?Lys?Val
50 55 60
Phe?Leu?Asp?Met?Lys?Leu?Leu?Asp?Ile?Asp?Asn?Thr?Ile?Ala?Lys?Gly
65 70 75 80
Val?Glu?Asn?Val?Ala?Lys?Met?Gly?Val?Ser?Met?Leu?Thr?Leu?His?Ala
85 90 95
Tyr?Pro?Lys?Ala?Met?Arg?Ala?Ala?Val?Glu?Ala?Ala?Arg?Gly?Ser?Asp
100 105 110
Leu?Cys?Leu?Leu?Gly?Val?Thr?Val?Leu?Thr?Ser?Met?Asp?Asn?Ala?Asp
115 120 125
Leu?Arg?Glu?Ala?Gly?Tyr?Phe?Asp?Asn?Ala?Glu?Thr?Leu?Val?Leu?Lys
130 135 140
Arg?Ala?Arg?Gln?Ala?His?Glu?Ala?Gly?Met?Gly?Gly?Ile?Val?Ala?Ser
145 150 155 160
Ala?Val?Glu?Ala?Gln?Ala?Ile?Arg?Gln?Ala?Val?Arg?Pro?Asp?Met?Ala
165 170 175
Ile?Val?Thr?Pro?Gly?Ile?Arg?Pro?Ala?Gly?Ser?Glu?Lys?Gly?Asp?Gln
180 185 190
Lys?Arg?Val?Met?Thr?Pro?Ala?Asp?Ala?Leu?Arg?Ala?Gly?Ala?Ser?His
195 200 205
Leu?Ile?Val?Ala?Arg?Pro?Ile?Val?Gly?Ala?Pro?Asp?Arg?Lys?Ala?Ala
210 215 220
Ala?Leu?Ala?Ile?Leu?Lys?Glu?Met?Arg?Ser?Ile?Gly?Arg?Ser
225 230 235
<210>4
<211>717
<212>DNA
<213〉Bacillus abortus (Brucella abortus)
<400>4
atgacgacag?aattgcacga?tgacgcatcc?gggcgcctga?tcgtgggcct?tgacgtgccg 60
acaattgccg?aggcggaaaa?ggtggtcgaa?gaactgggca?atgctgtttc?cttctacaag 120
atcggctatc?agcttgtttt?tgccggtggg?cttgatttcg?ccaaaagcct?tgtggcggcg 180
cgcaaaaaag?tcttcctcga?catgaagctg?ctcgatatcg?acaacacgat?tgccaaaggc 240
gtggaaaatg?tcgcgaagat?gggtgtttcc?atgctcacgc?ttcatgccta?tccgaaggca 300
atgcgtgcgg?cggtggaagc?cgccagaggg?tcggacctat?gccttttggg?cgtgacggtc 360
ctgacctcca?tggacaatgc?cgatcttcgg?gaagccggtt?atttcgacaa?tgcggaaacg 420
ctggtgctga?aacgtgcccg?tcaggcgcat?gaggccggta?tgggcggcat?tgtcgcctcg 480
gcggtggagg?cgcaggccat?tcgccaggcg?gttcgccccg?atatggccat?cgtcacaccg 540
ggcatccgcc?cggcagggag?cgagaagggc?gaccagaagc?gcgtgatgac?gccagccgat 600
gccttgaggg?ccggtgcgag?ccatctcatc?gtggcgcgcc?cgatcgtggg?cgcaccggat 660
cgcaaggcgg?cagcccttgc?catcctgaag?gaaatgcgct?cgattggaag?aagttag 717
<210>5
<211>25
<212>DNA
<213〉artificial sequence
<220>
<223>
<400>5
ggaattctca?atgtaaccaa?cttca 25
<210>6
<211>24
<212>DNA
<213〉artificial sequence
<220>
<223>
<400>6
aagcttagag?gtcatacctt?cctg 24
<210>7
<211>28
<212>DNA
<213〉artificial sequence
<220>
<223>
<400>7
cctctaagct?tatctgtttg?ctgatgcg 28
<210>8
<211>25
<212>DNA
<213〉artificial sequence
<220>
<223>
<400>8
cgggatccgc?gtttcggata?agatg 25
<210>9
<211>27
<212>DNA
<213〉artificial sequence
<220>
<223>
<400>9
ggaattcaag?tcttctcacc?cacatcc 27
<210>10
<211>24
<212>DNA
<213〉artificial sequence
<220>
<223>
<400>10
aagcttcgtc?atcgtgcaat?tctg 24
<210>11
<211>29
<212>DNA
<213〉artificial sequence
<220>
<223>
<400>11
tgacgaagct?tcgctcgatt?ggaagaagt 29
<210>12
<211>25
<212>DNA
<213〉artificial sequence
<220>
<223>
<400>12
cgggattccc?gttcgcctgt?aagga 25

Claims (6)

1. Brucella abortus recombinant strain strain is the bacterial strain that the capsular polysaccharide synthetic proteins gene among Bacillus abortus (Brucella abortus) the bacterial strain S19 and the deactivation of carboxyuridine phosphate decarboxylase gene are obtained;
Described capsular polysaccharide synthetic proteins is shown in the sequence 1 of sequence table; Described carboxyuridine phosphate decarboxylase is shown in the sequence 3 of sequence table.
2. recombinant bacterial strain as claimed in claim 1 is characterized in that: the encoding sequence of described capsular polysaccharide synthetic proteins is shown in the sequence 2 of sequence table; The encoding sequence of described carboxyuridine phosphate decarboxylase is shown in the sequence 4 of sequence table.
3. recombinant bacterial strain as claimed in claim 1 or 2 is characterized in that: described deactivation realizes by homologous recombination.
4. recombinant bacterial strain as claimed in claim 3 is characterized in that:
The homologous recombination of the described capsular polysaccharide synthetic proteins of described deactivation gene imports described Bacillus abortus bacterial strain S19 with dna fragmentation DA15 and realizes; Described dna fragmentation DA15 comprises homology arm DA15-1 and homology arm DA15-2 successively to the downstream from the upstream; Described homology arm DA15-1 is that the genomic dna with Bacillus abortus bacterial strain S19 is a template, and the primer of forming with sequence 5 and sequence 6 is to carrying out the dna fragmentation that pcr amplification obtains; Described homology arm DA15-2 is that the genomic dna with Bacillus abortus bacterial strain S19 is a template, and the primer of forming with sequence 7 and sequence 8 is to carrying out the dna fragmentation that pcr amplification obtains;
The homologous recombination of the described carboxyuridine phosphate decarboxylase gene of described deactivation imports described Bacillus abortus bacterial strain S19 with dna fragmentation DAT and realizes; Described dna fragmentation DAT comprises homology arm DAT-1 and homology arm DAT-2 successively to the downstream from the upstream; Described homology arm DAT-1 is that the genomic dna with Bacillus abortus bacterial strain S19 is a template, and the primer of forming with sequence 9 and sequence 10 is to carrying out the dna fragmentation that pcr amplification obtains; Described homology arm DAT-2 is that the genomic dna with Bacillus abortus bacterial strain S19 is a template, and the primer of forming with sequence 11 and sequence 12 is to carrying out the dna fragmentation that pcr amplification obtains.
5. the application of arbitrary described recombinant bacterial strain in preparation Bacillus abortus disease vaccine in the claim 1 to 4.
6. Bacillus abortus disease vaccine, its activeconstituents is arbitrary described Brucella abortus recombinant strain strain in the claim 1 to 4.
CN2009100858596A 2009-06-03 2009-06-03 Abortus Brucella vaccine recombinant strain and application thereof in preparing vaccine Expired - Fee Related CN101575587B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100858596A CN101575587B (en) 2009-06-03 2009-06-03 Abortus Brucella vaccine recombinant strain and application thereof in preparing vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100858596A CN101575587B (en) 2009-06-03 2009-06-03 Abortus Brucella vaccine recombinant strain and application thereof in preparing vaccine

Publications (2)

Publication Number Publication Date
CN101575587A CN101575587A (en) 2009-11-11
CN101575587B true CN101575587B (en) 2011-01-05

Family

ID=41270660

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100858596A Expired - Fee Related CN101575587B (en) 2009-06-03 2009-06-03 Abortus Brucella vaccine recombinant strain and application thereof in preparing vaccine

Country Status (1)

Country Link
CN (1) CN101575587B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2942389A1 (en) 2014-05-05 2015-11-11 Servicio Andaluz De Salud Vaccine against Acinetobacter baumannii based on lipopolysaccharide-deficient cellular components
CN105018489B (en) * 2015-08-07 2018-03-20 山东省农业科学院奶牛研究中心 Differentiate brucella street strain and vaccine strain A19 and S2 kit

Also Published As

Publication number Publication date
CN101575587A (en) 2009-11-11

Similar Documents

Publication Publication Date Title
CN101900731B (en) ELISA kit for distinctively detecting antibodies of classical swine fever (CSF) vaccine immunity and wild virus infection and preparation method thereof
Zhu et al. The surface display of haemolysin from Vibrio harveyi on yeast cells and their potential applications as live vaccine in marine fish
Wunder et al. A live attenuated-vaccine model confers cross-protective immunity against different species of the Leptospira genus
Stefanelli et al. Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs
CN102221618B (en) Method for establishing hog cholera lapinized virus labeled vaccine strain and preparing vaccine
CN101575587B (en) Abortus Brucella vaccine recombinant strain and application thereof in preparing vaccine
CN101386831B (en) Recombinant bacterium of brucella abortus with immunity labeling and use thereof
CN101629159B (en) Brucella abortus recombinant strain and application thereof
CN111057682B (en) Avian H9N2 subtype avian influenza strain separation identification and application
CN102747092A (en) Recombinant defective adenoviruses expressing O type foot and mouth disease virus empty capsid, and applications thereof
Thurnheer et al. Infinite serovar and ribotype heterogeneity among oral Fusobacterium nucleatum strains?
WO2018018041A1 (en) Design of protective anti-zikv vaccine without inducing cross-reactions with dengue
CN101386830B (en) Recombinant bacterium of brucella melitensis with immunity labeling and use thereof
CN101575589B (en) Abortus Brucella vaccine strain S19 marked recombinant strain and application thereof
CN101020894B (en) Avirulent type-2 pig streptococcus strain and its prepn and application
CN101629151B (en) Brucella abortus immune marking recombinant strain and application thereof in preparation of vaccine
CN101386833B (en) Recombinant bacterium of brucella abortus and use thereof
CN101386832B (en) Recombinant bacterium of brucella melitensis and use thereof
Paris et al. Orientia
CN101613402B (en) Surface protein of streptococcus suis 2-type and preparation method and application thereof
CN104248754A (en) Streptococcus suis vaccine composition, and preparation method and application thereof
CN104945513B (en) Streptococcus mutans cell surface protein antigen (SpaP) and glucosyltransferase (GtfB) amalgamation protein vaccine and preparation method thereof
CN103936842B (en) Pneumolysin mutants and the application as mucosal adjuvant thereof
CN101629152A (en) Brucella melitensis immune labeled recombinant strain and application thereof in preparation of vaccine
Austrian Bacterial polysaccharide vaccines

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110105

Termination date: 20150603

EXPY Termination of patent right or utility model